Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference
Quest Diagnostics (NYSE: DGX) announced that Sam Samad, executive vice president and chief financial officer, will speak at Citi's 2025 Global Healthcare Conference in Miami on Tuesday, December 2, 2025 at 3:15 p.m. ET.
The session will be a fireside chat with Q&A and will be webcast live on the company's investor relations page at ir.QuestDiagnostics.com. An archived webcast will be posted within 24 hours and will remain available through January 2, 2026.
Quest Diagnostics (NYSE: DGX) ha annunciato che Sam Samad, vicepresidente esecutivo e direttore finanziario, interverrà alla Citi's 2025 Global Healthcare Conference a Miami martedì 2 dicembre 2025 alle 15:15 ET.
La sessione sarà una chiacchierata informale con domande e risposte e sarà trasmessa in webcast live sul sito di investor relations dell'azienda all'indirizzo ir.QuestDiagnostics.com. Una versione webcast archiviata sarà pubblicata entro 24 ore e rimarrà disponibile fino al 2 gennaio 2026.
Quest Diagnostics (NYSE: DGX) anunció que Sam Samad, vicepresidente ejecutivo y director financiero, hablará en la Citi's 2025 Global Healthcare Conference en Miami el martes 2 de diciembre de 2025 a las 3:15 p.m. hora del Este.
La sesión será una charla junto al fuego con preguntas y respuestas y será transmitida en directo por webcast en la página de relaciones con inversionistas de la empresa en ir.QuestDiagnostics.com. Se publicará una versión en archivo del webcast dentro de las 24 horas y estará disponible hasta el 2 de enero de 2026.
Quest Diagnostics (NYSE: DGX)는 Sam Samad, 부사장 겸 최고재무책임자(CFO)가 Citi's 2025 Global Healthcare Conference에 마이애미에서 2025년 12월 2일 화요일 오후 3:15(동부표준시)에 발표할 것이라고 발표했습니다.
세션은 파이어사이드 챗과 Q&A 형식으로 진행되며 회사의 투자자 관계 페이지 ir.QuestDiagnostics.com에서 실시간 방송으로 중계될 예정입니다. 아카이브 웹캐스트는 24시간 이내에 게시되며 2026년 1월 2일까지 이용 가능할 것입니다.
Quest Diagnostics (NYSE: DGX) a annoncé que Sam Samad, vice-président exécutif et directeur financier, interviendra lors de la Citi's 2025 Global Healthcare Conference à Miami le Mardi 2 décembre 2025 à 15h15 ET.
La session sera un fireside chat avec Q&A et sera diffusée en direct en webcast sur la page des relations investisseurs de l'entreprise à l'adresse ir.QuestDiagnostics.com. Un webcast archivé sera publié dans les 24 heures et restera disponible jusqu'au 2 janvier 2026.
Quest Diagnostics (NYSE: DGX) gab bekannt, dass Sam Samad, Executive Vice President und Chief Financial Officer, auf der Citi's 2025 Global Healthcare Conference in Miami am Dienstag, 2. Dezember 2025, um 15:15 Uhr ET sprechen wird.
Die Sitzung wird ein Fireside-Chat mit Q&A sein und live gestreamt auf der Investor-Relations-Seite des Unternehmens unter ir.QuestDiagnostics.com. Eine archivierte Webcast wird innerhalb von 24 Stunden online gestellt und bis zum 2. Januar 2026 verfügbar sein.
Quest Diagnostics (NYSE: DGX) أعلنت أن Sam Samad، نائب الرئيس التنفيذي والمدير المالي، سيتحدث في Citi's 2025 Global Healthcare Conference في ميامي يوم الثلاثاء 2 ديسمبر 2025 الساعة 3:15 مساءً بتوقيت شرق الولايات المتحدة.
ستكون الجلسة دردشة أمام المدفأة مع أسئلة وأجوبة وستكون بثًا حيًا عبر الويب على صفحة علاقات المستثمرين الخاصة بالشركة على ir.QuestDiagnostics.com. وسيتم نشر بث ويب أرشيفي خلال 24 ساعة وسيظل متاحًا حتى 2 يناير 2026.
- None.
 
- None.
 
                  
The fireside chat and Q&A session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until January 2, 2026.
                  About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in 
                  
 View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-citis-2025-global-healthcare-conference-302603103.html
SOURCE Quest Diagnostics